13G Filing: Partner Fund Management and Endologix Inc (ELGX)

Page 13 of 13

Page 13 of 13 – SEC Filing

CUSIP No. 29266S106 13G Page 13 of 13 Pages

After reasonable inquiry
and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true,
complete and correct.

Dated this 1st day of June, 2017.

PARTNER FUND MANAGEMENT, L.P.

 

By:        Partner
Fund Management GP, LLC its general partner

By:        /s/ Darin Sadow

Darin Sadow, Authorized Signatory

 

PARTNER FUND MANAGEMENT GP, LLC

By:        /s/ Darin Sadow

Darin Sadow, Authorized Signatory

 

PARTNER INVESTMENT MANAGEMENT, L.P.

 

By:        Partner
Investment Management GP, LLC, its general partner

By:        /s/ Darin Sadow

Darin Sadow, Authorized Signatory

 

PARTNER INVESTMENT MANAGEMENT GP, LLC

By:        /s/ Darin Sadow

Darin Sadow, Authorized Signatory

 

BRIAN D. GROSSMAN

By:        /s/ Darin Sadow

Darin Sadow,
attorney-in-fact
*

 

CHRISTOPHER M. JAMES

By:        /s/ Darin Sadow

Darin Sadow, attorney-in-fact**

 


* Darin Sadow is signing on behalf of Brian Grossman as attorney-in-fact
pursuant to a power of attorney dated August 4, 2011, and incorporated by reference herein. The power of attorney was filed as
an attachment to a filing by certain of the Reporting Persons on Schedule 13G for K-V Pharmaceutical Company on August 5, 2011.
** Darin Sadow is signing on behalf of Christopher M. James as attorney-in-fact pursuant to a power of
attorney dated August 4, 2011, and incorporated by reference herein. The power of attorney was filed as an attachment to a filing
by certain of the Reporting Persons on Schedule 13G for K-V Pharmaceutical Company on August 5, 2011.

Follow Endologix Inc (NASDAQ:ELGX)

Page 13 of 13